WealthBridge Investment Counsel’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.75M | Buy |
11,725
+238
| +2% | +$96.5K | 1.54% | 29 |
|
|
2025
Q1 | $5.72M | Buy |
11,487
+265
| +2% | +$132K | 2.08% | 25 |
|
|
2024
Q4 | $5.84M | Buy |
11,222
+105
| +0.9% | +$54.6K | 2.14% | 26 |
|
|
2024
Q3 | $6.88M | Buy |
11,117
+225
| +2% | +$139K | 2.44% | 22 |
|
|
2024
Q2 | $6.02M | Buy |
10,892
+417
| +4% | +$231K | 2.3% | 22 |
|
|
2024
Q1 | $6.09M | Sell |
10,475
-10
| -0.1% | -$5.81K | 2.26% | 24 |
|
|
2023
Q4 | $5.57M | Buy |
10,485
+24
| +0.2% | +$12.7K | 2.23% | 26 |
|
|
2023
Q3 | $5.3M | Buy |
10,461
+221
| +2% | +$112K | 2.31% | 22 |
|
|
2023
Q2 | $5.34M | Buy |
10,240
+1,170
| +13% | +$610K | 2.25% | 24 |
|
|
2023
Q1 | $5.23M | Buy |
9,070
+215
| +2% | +$124K | 2.31% | 24 |
|
|
2022
Q4 | $4.88M | Buy |
8,855
+728
| +9% | +$401K | 2.13% | 25 |
|
|
2022
Q3 | $4.12M | Buy |
8,127
+585
| +8% | +$297K | 2.17% | 26 |
|
|
2022
Q2 | $4.1M | Buy |
7,542
+350
| +5% | +$190K | 2.08% | 28 |
|
|
2022
Q1 | $4.25M | Buy |
7,192
+507
| +8% | +$299K | 1.88% | 29 |
|
|
2021
Q4 | $4.46M | Sell |
6,685
-10
| -0.1% | -$6.67K | 1.89% | 27 |
|
|
2021
Q3 | $3.83M | Sell |
6,695
-150
| -2% | -$85.7K | 1.72% | 27 |
|
|
2021
Q2 | $3.45M | Buy |
6,845
+580
| +9% | +$293K | 1.53% | 29 |
|
|
2021
Q1 | $2.86M | Buy |
6,265
+365
| +6% | +$167K | 1.4% | 29 |
|
|
2020
Q4 | $2.75M | Buy |
5,900
+430
| +8% | +$200K | 1.44% | 29 |
|
|
2020
Q3 | $2.42M | Buy |
5,470
+135
| +3% | +$59.6K | 1.47% | 28 |
|
|
2020
Q2 | $1.93M | Buy |
5,335
+75
| +1% | +$27.2K | 1.28% | 28 |
|
|
2020
Q1 | $1.49M | Buy |
5,260
+175
| +3% | +$49.6K | 1.27% | 26 |
|
|
2019
Q4 | $1.65M | Buy |
+5,085
| New | +$1.65M | 0.94% | 32 |
|